From Candide to Candide

Description

In 2050, CC22 is 22 years old. He is the 22nd clone of Candide, who is making a fortune thanks to nanoparticle and genome manipulation. But CC22 doesn’t live up to his father’s candid expectations. He rebels by any means he can invent. Praises idleness. Contemplates. Befriends Psalmonella. Eats all-you-can-eat carpaccio-cocoa. Changes mantra every day. Grows…
***
Are living things infinitely expandable? To what extent? What technical, ethical and political horizon does transhumanism offer our shared humanity? De Candide à Candide, controverse sur le transhumanisme tackles these questions about the future of humanity by bringing together an anticipation tale, 36 original drawings by Hélène Paris and a humanities and social sciences approach (Daniel Kaplan, Olivier Fournout).

The author

Olivier Fournout is a researcher at the Institut Interdisciplinaire de l’Innovation (UMR CNRS) and a lecturer in social sciences at Telecom Paristech. He works on bridges between societies and fictional worlds, between art and science, and between management and cinema. He accompanies collective artistic creations around ecological and relational issues, and scientific controversies… He hosts performance-fictions (iledenface.com) on prospective themes. He is the author of “Théorie de la communication et éthique relationnelle” (Hermès-Lavoisier, 2012), “Héros. Action, innovation, interaction dans les organisations et au cinéma” (Presses des Mines, 2014) and a novel (“Le nain”, Tsémah, 2014). He is a founding member of the Université de la Pluralité (2018).

 

 

Candide Candide is an illustrated tale of anticipation. It is part of a broader, collective approach to fictionalizing controversies concerning the future of humanity, in novels, theater, poetry, sound, video and graphics.

The imaginary, in its own way, diagnoses the present, participates in public debate, and builds the future.
Questions of foresight, ethics and politics around transhumanism are addressed in the afterwords, with information on the genesis of the project and the challenges of transhumanism today and tomorrow.